Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention

BACKGROUND: Eptifibatide is a platelet glycoprotein IIb/IIIa receptor antagonist used for the prevention of cardiac ischemic complications of percutaneous coronary intervention (PCI). Eptifibatide has been used with bolus dose only or bolus plus infusion in patients undergoing PCI which have shown l...

Descripción completa

Detalles Bibliográficos
Autores principales: Doustkami, Hossein, Sadeghieh Ahari, Saeed, Irani Jam, Effat, Habibzadeh, Afshin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942240/
https://www.ncbi.nlm.nih.gov/pubmed/29755628
http://dx.doi.org/10.14740/cr675w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942240/
https://www.ncbi.nlm.nih.gov/pubmed/29755628
http://dx.doi.org/10.14740/cr675w

Ejemplares similares